9 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $982M | -$416M | 64.5% | -44.5% | 419.2% | -20.7% | -$233M | $1.5B | $378M |
| 2024 | $739M | -$436M | 60.8% | -60.0% | 312.5% | -29.4% | -$275M | $1.1B | $526M |
| 2023 | $564M | -$479M | 59.7% | -100.1% | -302.1% | -26.8% | -$345M | — | $1.1B |
| 2022 | — | -$655M | — | — | -1087.7% | -40.7% | -$387M | — | $142M |
| 2021 | — | -$385M | — | — | -59.7% | -17.5% | -$284M | — | $492M |
| 2019 | — | -$76M | — | — | -9.5% | -7.9% | -$66M | — | $143M |
| 2018 | — | -$85M | — | — | -17.6% | -14.5% | -$92M | — | $141M |
| 2017 | — | -$83M | — | — | -27.0% | -24.3% | -$79M | — | $72M |
| 2016 | — | -$46M | — | — | -57.9% | — | -$38M | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jun '26 | $335M | -$120M | 65.4% | -38.5% | 53.9% | -6.3% | -$70M | $1.5B | $1.1B |
| Mar '26 | $302M | -$112M | 65.2% | -40.2% | 61.9% | -5.9% | -$71M | $1.5B | $989M |
| Dec '25 | $281M | -$128M | 64.6% | -43.0% | 129.4% | -6.4% | -$54M | $1.5B | $378M |
| Sep '25 | $265M | -$93M | 64.7% | -37.3% | 26.2% | -7.3% | -$46M | $1.1B | $580M |
| Jun '25 | $232M | -$100M | 65.0% | -45.9% | 32.7% | -7.5% | -$66M | $1.1B | $629M |
| Mar '25 | $203M | -$95M | 63.3% | -54.6% | 37.9% | -7.1% | -$67M | $1.1B | $699M |
| Dec '24 | $202M | -$111M | 61.6% | -62.4% | 79.5% | -7.5% | -$83M | $1.1B | $526M |
| Sep '24 | $191M | -$108M | 61.1% | -61.3% | 179.3% | -7.0% | -$55M | — | $585M |
| Jun '24 | $177M | -$103M | 59.1% | -56.8% | 6362.6% | -6.4% | -$99M | — | $934M |
| Mar '24 | $168M | -$115M | 61.2% | -59.2% | -168.4% | -6.7% | -$37M | — | $1.0B |
| Dec '23 | — | -$187M | — | — | -117.9% | -10.5% | -$83M | — | $1.1B |
| Sep '23 | — | -$86M | — | — | -37.7% | -4.8% | -$80M | — | $457M |
| Jun '23 | — | -$73M | — | — | -24.9% | -4.0% | -$101M | — | $271M |
| Mar '23 | — | -$134M | — | — | 299.7% | -8.8% | -$82M | — | $224M |
| Dec '22 | — | -$140M | — | — | -232.5% | -8.7% | -$101M | — | $142M |
| Sep '22 | — | -$162M | — | — | -97.2% | -9.5% | -$100M | — | $158M |
| Jun '22 | — | -$229M | — | — | -71.9% | -12.4% | -$135M | — | $215M |
| Mar '22 | — | -$123M | — | — | -23.1% | -5.8% | -$51M | — | $574M |
| Dec '18 | — | -$25M | — | — | -5.2% | -4.3% | -$29M | — | $141M |
| Sep '18 | — | -$24M | — | — | -9.6% | -7.1% | -$28M | — | $114M |
How the market has priced GH against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Guardant Health, Inc.'s revenue has grown 32.0% per year. These are computed facts, not advice.
As of FY2025, Guardant Health, Inc. reported $1.5B of total debt against $378M of cash; operating income covered interest expense -112.2×.
In FY2025, gross margin was 64.5%, operating margin -44.5%, and net margin -42.4%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.